ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 219,14
0,38%
Dow Jones
39 512,84
0,32%
DAX
18 772,85
0,50%
Brent Oil
82,585
0,00%
Bitcoin
60 895,82
0,17%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Co Diagnostics Inc (CODX)

  7. Co Diagnostics Inc (CODX) Actualités

CODX Co Diagnostics Inc

1,11
-0,12 (-9,76%)
11 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Co Diagnostics Inc CODX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,12 -9,76% 1,11 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,17 1,03 1,19 1,11 1,23
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
09/5/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:01EDGAR2Form 8-K - Current report
09/5/202422:01PRNUSCo-Diagnostics, Inc. Reports First Quarter 2024 Financial..
25/4/202415:30PRNUSCo-Diagnostics, Inc. Announces First Quarter 2024 Earnings..
24/4/202415:30PRNUSCo-Diagnostics, Inc. to Host Booth and Deliver Presentation..
12/4/202415:30PRNUSCo-Diagnostics, Inc. Inaugurates New Manufacturing Facility..
04/4/202415:30PRNUSCo-Diagnostics, Inc. Appoints New President and Other..
21/3/202414:30PRNUSCo-Diagnostics, Inc. CEO Delivers Manufacturing and..
18/3/202414:30PRNUSCo-Diagnostics, Inc. CEO to Deliver Keynote Address at..
14/3/202421:01PRNUSCo-Diagnostics, Inc. Reports Full Year 2023 Financial..
07/3/202415:30PRNUSCo-Diagnostics, Inc. JV CoSara Receives Clearance from..
29/2/202415:30PRNUSCo-Diagnostics, Inc. Announces Fourth Quarter and Full Year..
01/2/202415:30PRNUSCo-Diagnostics, Inc. Shares List of Upcoming Industry..
03/1/202415:30PRNUSCo-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12
27/12/202315:30PRNUSCo-Diagnostics, Inc. Completes Submission to FDA for Co-Dx..
29/11/202315:30PRNUSCo-Diagnostics, Inc. to Participate in the Piper Sandler..
27/11/202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:01EDGAR2Form 8-K - Current report
09/11/202322:01PRNUSCo-Diagnostics, Inc. Reports Third Quarter 2023 Financial..
02/11/202314:30PRNUSCo-Diagnostics, Inc. Announces Additional Grant Award for..
31/10/202314:30PRNUSCo-Diagnostics, Inc. Shares List of Upcoming Industry..
26/10/202315:30PRNUSCo-Diagnostics, Inc. Announces Third Quarter 2023 Earnings..
23/10/202315:30PRNUSCo-Diagnostics, Inc. to Host Booth at CASMET Symposium..
16/10/202315:30PRNUSCo-Diagnostics, Inc. to Host Booth at Medlab Africa 2023 in..
27/9/202315:30PRNUSCo-Diagnostics, Inc. to Participate in the 2023 UHCA/UCAL..
22/9/202315:30PRNUSCo-Diagnostics, Inc. to Participate in 6th ACTC Conference..
21/9/202315:30PRNUSCo-Diagnostics, Inc. to Participate in Gilmartin Group..
07/9/202315:30PRNUSCo-Diagnostics, Inc. to Participate in the H.C. Wainwright..
31/8/202322:05EDGAR2Form 8-K - Current report
29/8/202315:30PRNUSCo-Diagnostics, Inc. Appoints Chief Regulatory Affairs..
18/8/202315:30PRNUSCo-Diagnostics, Inc. to Present at 15th Next Generation Dx..
16/8/202317:30PRNUSCo-Diagnostics, Inc. to Host Booth at Medlab Asia Conference..
10/8/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:03EDGAR2Form 8-K - Current report
10/8/202322:01PRNUSCo-Diagnostics, Inc. Reports Second Quarter 2023 Financial..
27/7/202315:30PRNUSCo-Diagnostics, Inc. Announces Second Quarter 2023 Earnings..
20/7/202315:30PRNUSCo-Diagnostics, Inc. to Host Booth and Discuss Recent Grant..
20/7/202312:10EDGAR2Form DEF 14A - Other definitive proxy statements
18/7/202315:30PRNUSCo-Diagnostics, Inc. Announces Recent Grant Awards
13/7/202315:30PRNUSCo-Diagnostics, Inc. Awarded Funding for Co-Dx PCR Home..

Dernières Valeurs Consultées

NASDAQ
CODX
Co Diagnostics
NASDAQ
NTBL
Notable Labs
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés